2021 Policy Leadership Breakfast

January 27, 2021 9:00 AM - 11:00 AM

Webinar, click "live-stream" button to view

Add to Calendar 1/27/2021 9:00:03 AM 1/27/2021 11:00:03 AM 2021 Policy Leadership Breakfast Please join us on Wednesday, January 27th for what has proven to be the must-attend event for senior industry leaders, policymakers and life sciences government affairs executives.
 

At this year’s Policy Breakfast, we will virtually convene senior life sciences industry leaders and government relations professionals with state and federal policymakers and their staff to discuss the most important policy issues facing the life sciences and the potential impact on patients and their access to breakthrough therapies and cures. The agenda will feature a panel discussion on how to ensure effective, efficient, and equitable distribution of COVID-19 vaccines, especially to those communities disproportionately impacted by the pandemic, and how properly educate the public on the safety, efficacy, and necessity of vaccines.

MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Webinar, click "live-stream" button to view
Vice President, Worldwide Research and Development, Pfizer
Margaret Ruesch is a Vice President in Worldwide Research and Development at Pfizer. She is a leader in Biotherapeutics Pharmaceutical Sciences, a multi-site organization of scientists and engineers who develop the complex manufacturing and testing strategies for Pfizer’s portfolio of biotherapeutics, gene therapies, and vaccines. Margaret is also the R&D site leader for Pfizer’s Andover, MA location. Andover is a joint R&D and commercial manufacturing site and plays a critical role in the development and manufacturing of new biotherapeutics, gene therapies, and vaccines. Margaret received a B.S. in Biology from The University of Notre Dame and a Ph.D. in Cancer Biology from Northwestern University. She has 20 years of experience in biopharmaceutical and vaccine development and has held previous scientific and leadership roles at Abbott Laboratories in Chicago; Pharmacia & Upjohn in Kalamazoo, MI; and Pfizer in St. Louis, MO. Margaret currently resides in Lexington, MA.

Brought to you by